Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|January 5, 2002
7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubilityPier Giovanni Baraldi, Barbara Cacciari, Romeo Romagnoli, et al.
International Journal of Medicinal Chemistry|May 9, 2015
Pyrazolo derivatives as potent adenosine receptor antagonists: an overview on the structure-activity relationshipsSiew Lee Cheong, Gopalakrishnan Venkatesan, Priyankar Paira, et al.
Farmaco (Societa Chimica Italiana : 1989)|January 18, 2005
Synthesis and biological evaluation of new phenidone analogues as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitorsClaudia Cusan, Giampiero Spalluto, Maurizio Prato, et al.
European Journal of Medicinal Chemistry|December 31, 2015
5,7-Disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazines as pharmacological tools to explore the antagonist selectivity profiles toward adenosine receptorsStephanie Federico, Antonella Ciancetta, Nicola Porta, et al.
Medicinal Research Reviews|November 19, 2011
The A3 adenosine receptor as multifaceted therapeutic target: pharmacology, medicinal chemistry, and in silico approachesSiew Lee Cheong, Stephanie Federico, Gopalakrishnan Venkatesan, et al.
Plos One|December 2, 2015
The Influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl Moiety on the Adenosine Receptors Affinity Profile of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine DerivativesStephanie Federico, Sara Redenti, Mattia Sturlese, et al.
Journal of Medicinal Chemistry|October 27, 2012
Exploring the directionality of 5-substitutions in a new series of 5-alkylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine as a strategy to design novel human a(3) adenosine receptor antagonistsStephanie Federico, Antonella Ciancetta, Davide Sabbadin, et al.
Farmaco (Societa Chimica Italiana : 1989)|April 26, 2005
Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitorsClaudia Cusan, Giampiero Spalluto, Maurizio Prato, et al.
Journal of Chemical Information and Modeling|November 14, 2009
Exploring potency and selectivity receptor antagonist profiles using a multilabel classification approach: the human adenosine receptors as a key studyLisa Michielan, Federico Stephanie, Lothar Terfloth, et al.
Bioorganic & Medicinal Chemistry Letters|April 23, 2011
Pharmacophore elucidation for a new series of 2-aryl-pyrazolo-triazolo-pyrimidines as potent human A3 adenosine receptor antagonistsSiew Lee Cheong, Stephanie Federico, Gopalakrishnan Venkatesan, et al.
Pageof 9